Myasthenia gravis (MG) is an autoimmune disease characterized by impaired neuromuscular junction transmission. Its main feature is muscle fatigue, which usually worsens after activity and improves after rest and treatment with acetylcholinesterase drugs. The following is a detailed introduction to myasthenia gravis and an overview of the latest treatment methods:

1、 Introduction to Myasthenia Gravis

Etiology: The pathogenesis of myasthenia gravis involves damage to the acetylcholine receptors (AChR) on the postsynaptic membrane of the neuromuscular junction, leading to a decrease in the number of receptors and thus affecting the normal transmission of neuromuscular signals.

Clinical manifestations: Patients often experience clinical symptoms such as ptosis, diplopia, choking on water, and difficulty swallowing. The symptoms of myasthenia gravis are prone to fluctuations, worsening in the afternoon or evening after fatigue, and decreasing in the morning and after rest, that is, mild in the morning and severe in the evening.

Prone population: Myasthenia gravis is more likely to occur in individuals with immune disorders, individuals with thymic abnormalities, and those with a familial genetic predisposition.

2、 Latest treatment methods

Comprehensive treatment of nerve repair:

Overview: Comprehensive treatment of nerve repair is a new therapy in the field of myasthenia gravis treatment in recent years. It combines various methods such as drug therapy, surgical treatment, physical therapy, psychological therapy, etc., aiming to comprehensively promote the recovery of nerve function.

Effect: By comprehensively applying these technologies, patients' muscle weakness symptoms, including limb weakness, muscle atrophy, eyelid droop, etc., can be significantly improved, thereby improving the quality of life of patients.

medication:

Anticholinergic drugs, such as neostigmine, are used to supplement hormones that cause muscle weakness, but should not be used alone for a long time.

Immunosuppressive drugs: including glucocorticoids (such as methylprednisolone) and other immunosuppressants (such as cyclophosphamide, azathioprine, etc.). For difficult to treat cases, potent immunosuppressants such as tacrolimus can be considered.

High dose infusion of human immunoglobulin: used continuously for five days as an adjuvant therapy.

Surgical treatment:

Thymectomy: For patients with positive acetylcholine receptors, thymectomy has a good effect and can significantly improve symptoms.

Other treatments:

Physical therapy, such as rehabilitation training, can help enhance muscle strength and endurance.

Psychological therapy: For patients with myasthenia gravis, maintaining a good mentality and positive psychological state is crucial for the treatment and recovery of the disease.

In summary, the treatment of myasthenia gravis requires comprehensive consideration of the patient's specific situation and the development of personalized treatment plans. By comprehensively utilizing various treatment methods, patients' symptoms can be significantly improved and their quality of life can be enhanced.